Onderneming Concert Pharmaceuticals, Inc.
Aandelen
CNCE
US2060221056
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 64
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Roger Tung
FOU | Founder | 64 | 12-04-06 |
Marc A. Becker
DFI | Director of Finance/CFO | 52 | 04-01-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-08 | |
Virginia Braman
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-20 |
Nancy Stuart
COO | Chief Operating Officer | 65 | 01-07-06 |
Investor Relations Contact | - | 01-03-08 | |
Kimberly Mack
HRO | Human Resources Officer | - | 01-10-06 |
Nabil Uddin
PRN | Corporate Officer/Principal | - | 01-01-14 |
General Counsel | 47 | 23-09-19 | |
General Counsel | - | 06-09-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roger Tung
FOU | Founder | 64 | 12-04-06 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 48 138 789 | 43 915 652 ( 91,23 %) | 200 601 ( 0,4167 %) | 91,23 % |
Aandeel B | 0 | 20 746 | 0 | 0 |
Bedrijfsgegevens
Concert Pharmaceuticals, Inc.
65 Hayden Avenue Suite 3000N
02421, Lexington
+781 860 0045
http://www.concertpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,75% | 43,43 mld. | |
+47,87% | 41,69 mld. | |
+8,65% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+8,75% | 25,28 mld. | |
-24,71% | 18,47 mld. | |
+33,38% | 12,59 mld. | |
+1,30% | 12,33 mld. | |
+8,82% | 11,03 mld. |